ArticlePloS one2022

Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma.

Young-Ran Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.